[From nobody Sat Dec 21 13:52:58 2024 Return-Path: <sentto-2425310-13470-1227907994-rebelljb=aol.com@returns.groups.yahoo.com> Received: from rly-df04.mx.aol.com (rly-df04.mail.aol.com [172.19.156.17]) by air-df06.mail.aol.com (v121_r4.4) with ESMTP id MAILINDF063-544493063b0330; Fri, 28 Nov 2008 16:34:00 -0500 Received: from n16a.bullet.scd.yahoo.com (n16a.bullet.scd.yahoo.com [66.94.237.45]) by rly-df04.mx.aol.com (v121_r4.4) with ESMTP id MAILRELAYINDF043-544493063b0330; Fri, 28 Nov 2008 16:33:37 -0500 Comment: DomainKeys? See http://antispam.yahoo.com/domainkeys DomainKey-Signature: a=rsa-sha1; q=dns; c=nofws; s=lima; d=yahoogroups.com; b=RqKh4D3B7mfnSaPzRhwMWbxaNrSdGVEWbHtplN6FTMKF1MXgtmbl4COC818eBS9a3tRadExBJiV5LwZCiHdr/N3BNVdFa2kcxH+fylUfEh4cMCASRUFlX5lvqbXV9UO6; Received: from [66.218.69.1] by n16.bullet.scd.yahoo.com with NNFMP; 28 Nov 2008 21:33:14 -0000 Received: from [69.147.65.171] by t1.bullet.scd.yahoo.com with NNFMP; 28 Nov 2008 21:33:14 -0000 Received: from [66.218.67.104] by t13.bullet.mail.sp1.yahoo.com with NNFMP; 28 Nov 2008 21:33:14 -0000 X-Yahoo-Newman-Id: 2425310-m13470 X-Sender: Rebelljb@aol.com X-Apparently-To: wildestcolts@yahoogroups.com X-Received: (qmail 8072 invoked from network); 28 Nov 2008 21:33:12 -0000 X-Received: from unknown (66.218.67.96) by m43.grp.scd.yahoo.com with QMQP; 28 Nov 2008 21:33:12 -0000 X-Received: from unknown (HELO imo-d04.mx.aol.com) (205.188.157.36) by mta17.grp.scd.yahoo.com with SMTP; 28 Nov 2008 21:33:11 -0000 X-Received: from Rebelljb@aol.com by imo-d04.mx.aol.com (mail_out_v39.1.) id r.d45.35f17c4b (42805) for <wildestcolts@yahoogroups.com>; Fri, 28 Nov 2008 16:33:04 -0500 (EST) Message-ID: <d45.35f17c4b.3661bd90@aol.com> To: wildestcolts@yahoogroups.com X-Mailer: 9.0 Security Edition for Windows sub 5380 X-Spam-Flag: NO X-Originating-IP: 205.188.157.36 X-eGroups-Msg-Info: 1:12:0:0:0 From: rebelljb@aol.com Sender: wildestcolts@yahoogroups.com MIME-Version: 1.0 Mailing-List: list wildestcolts@yahoogroups.com; contact wildestcolts-owner@yahoogroups.com Delivered-To: mailing list wildestcolts@yahoogroups.com List-Id: <wildestcolts.yahoogroups.com> Precedence: bulk List-Unsubscribe: <mailto:wildestcolts-unsubscribe@yahoogroups.com> Date: Fri, 28 Nov 2008 16:33:04 EST Subject: [wildestcolts] Fwd: The Washington Post - Ailing FDA May Need a Major Overhaul, Officials a... Reply-To: wildestcolts@yahoogroups.com X-Yahoo-Newman-Property: groups-email-ff-m Content-Type: multipart/alternative; boundary="ae0JBvv8mj4sUY8uwu4aZQ09X2HVQhy2gLGyPMn" X-AOL-IP: 66.94.237.45 --ae0JBvv8mj4sUY8uwu4aZQ09X2HVQhy2gLGyPMn Content-Type: text/plain; charset=ISO-8859-1 Content-Transfer-Encoding: quoted-printable =20 In a message dated 11/28/2008 10:52:41 A.M. Central Standard Time, =20 vince_19805@yahoo.com writes: **** note: This is a private list. I send out alerts, useful news items= ,=20 and comment to a group of mental health professionals, decision makers and=20 activists. (OK to repost and to include this header and comments). If you=20= do=20 not want to receive any of these emails, please let me know. To preserve=20 privacy, I blind copy the entire list. Vince Boehm ****=20 _http://www.washingtonpost.com/wp-dyn/content/article/2008/11/25/AR200811250= 22 19_pf.html_=20 (http://www.washingtonpost.com/wp-dyn/content/article/2008/11/25/AR200811250= 2219_pf.html)=20 Ailing FDA May Need a Major Overhaul, Officials and Groups Say _Post a comment_=20 (http://www.washingtonpost.com/wp-dyn/content/article/2008/11/25/AR200811250= 2219_Comments.html) =20 By Rob Stein Washington Post Staff Writer Wednesday, November 26, 2008; A02 The _Obama_=20 (http://www.washingtonpost.com/ac2/related/topic/Barack+Obama?tid=3Dinformli= ne) administration will inherit a _Food and Drug Administration_=20 (http://www.washingtonpost.com/ac2/related/topic/Food+and+Drug+Administratio= n?tid =3Dinformline) widely seen as struggling to protect Americans from unsafe=20 medication, contaminated food and a flood of questionable imports from Chin= a and=20 other countries.=20 Shaken by a series of alarming failures, the FDA desperately needs an=20 infusion of strong leadership, money, technology and personnel -- and perha= ps a=20 major restructuring, say former officials, members of Congress, watchdog gr= oups =20 and various government reports.=20 "Everywhere you go, you hear the same chorus: The agency's in trouble," sai= d=20 David A. Kessler, who served as FDA commissioner under Presidents _George=20 H.W. Bush_=20 (http://www.washingtonpost.com/ac2/related/topic/George+H.W.+Bush?tid=3Dinfo= rmline) and _Bill Clinton_=20 (http://www.washingtonpost.com/ac2/related/topic/Bill+Clinton?tid=3Dinformli= ne) . "There's a general perception the agency is=20 suffering mightily."=20 With nearly 11,000 employees and an annual budget of more than $2 billion,=20 the FDA is charged with overseeing products that account for one-quarter of= =20 consumer spending in the United States, including over-the-counter and =20 prescription medications, heart valves, stents and other medical devices, t= he blood=20 supply, and food.=20 But morale within the FDA, along with its credibility outside, has plummete= d=20 as the agency has been stretched to keep pace with its responsibilities and= =20 riven by accusations of ideological bias, a tilt toward industry rather than= =20 consumers, and internal dissension.=20 "FDA is close to being at a tipping point -- the agency is hanging on by it= s=20 fingertips in protecting us," said William K. Hubbard, who worked for the =20 agency for 27 years. "If something is not done, they could become a failed =20 institution, and no one wants that. The FDA is not only important to protec= ting=20 the public health but also to the industries it regulates."=20 Alarm about the agency began to spike after a series of highly publicized =20 incidents, including the discovery that the painkiller _Vioxx_=20 (http://www.washingtonpost.com/ac2/related/topic/Vioxx?tid=3Dinformline) ca= used heart attacks.=20 That has been followed by other safety issues, including questions about th= e=20 widely used diabetes medication _Avandia_=20 (http://www.washingtonpost.com/ac2/related/topic/Avandia?tid=3Dinformline) =20= and several psychiatric drugs.=20 "I'm afraid we're going to see more horrible things happen if we don't get=20 our act together on this," said _David Ross_=20 (http://www.washingtonpost.com/ac2/related/topic/David+Ross?tid=3Dinformline= ) , who was a drug reviewer at the=20 agency for 10 years.=20 At the same time, there has been increasing alarm about the agency's abilit= y=20 to protect the food supply -- concerns highlighted by recent major outbreak= s=20 of E. coli infection in spinach and salmonella in spinach and peppers. Tha= t=20 has prompted calls to split the agency in two -- with one dedicated to drug= s=20 and the other to food.=20 "Food safety tends to get short shrift," said Christopher Waldrop of the=20 _Consumer Federation of America_=20 (http://www.washingtonpost.com/ac2/related/topic/Consumer+Federation+of+Amer= ica?tid=3Dinformline) . "The drug side tends to get =20 much more attention than the food side. Food is equally important and needs=20= =20 to get the attention it deserves."=20 Both the food and drug parts of the FDA's responsibilities have been hobble= d=20 by its inability to adequately monitor goods pouring into the United States= =20 from around the world, including food, drugs and raw materials, many say. =20 Such concerns were highlighted by contaminated toothpaste from China; taint= ed=20 pet food that killed hundreds of dogs and cats; and the fouled blood thinne= r=20 heparin, which took the lives of at least 81 Americans and caused hundreds=20= of=20 serious illnesses.=20 "The agency is still stuck at the border," said Carl R. Nielsen, who was in= =20 charge of the FDA's import operations for the last six of his 28 years at =20 the agency. "There has to be radical reorganization -- no doubt about that.= "=20 Although the FDA has started opening offices overseas to try to better=20 police safety standards at the source, experts say much more needs to be do= ne. For=20 starters, the agency needs to sharply boost inspections abroad, develop=20 strict new regulatory standards, and update and integrate its computer syst= ems,=20 which are woefully antiquated and disjointed, Nielsen and others said.=20 "It's still largely a paper-driven agency," Nielsen said. "The agency has=20 great information pigeonholed all over the place, but it cannot be applied=20= in=20 real time, which is what you need today."=20 The FDA has also been one of the many federal agencies where Bush=20 administration critics say ideology has trumped science, citing the long de= lay in=20 approving the over-the-counter sale of the emergency contraceptive Plan B.= =20 "The agency needs to get back to using science as the basis for its =20 decision-making," said Jane E. Henney, who ran the FDA under Clinton from 1= 998 to=20 2001.=20 Questions have also been raised about the agency's handling of suspected=20 toxins such as bisphenol A in baby bottles and other products. And internal= =20 dissension has erupted publicly from the usually hermetically sealed agency= . Last=20 week, the _House Energy and Commerce Committee_=20 (http://www.washingtonpost.com/ac2/related/topic/U.S.+House+Committee+on+Ene= rgy+and+Commerce?tid=3Dinformline) released a letter from FDA scientists complaining about "serious=20 misconduct" by top managers who oversee medical devices.=20 The turmoil comes as the FDA is facing a host of new demands, including the= =20 next wave of drugs and other products resulting from breakthroughs in=20 genetics, nanotechnology and bioengineered foods, among others. And Congres= s may=20 give the FDA the power to regulate tobacco for the first time.=20 "This would be a totally new regulatory responsibility that the FDA doesn't= =20 have expertise in," said Mark B. McClellan, who led the agency in President= =20 _George W. Bush_=20 (http://www.washingtonpost.com/ac2/related/topic/George+W.+Bush?tid=3Dinform= line) 's first term.=20 While the agency has received some additional money and personnel to help =20 implement new drug safety powers, many say it is overdue for a doubling of =20= its=20 budget.=20 "There's broad bipartisan recognition from consumer groups and from industr= y=20 that the FDA needs more resources," McClellan said. "The most important=20 thing is overall effective leadership that leads in a way that establishes=20= public=20 trust."=20 Many hope the new administration will quickly name a new FDA commissioner -= -=20 a post that has frequently been left in the hands of acting commissioners=20 for long periods. An acting commissioner ran the agency for more than half=20= of =20 the past eight years.=20 "The FDA can't be left to drift," said Hubbard, the former official.=20 "There's a lack of leadership when a caretaker is in charge, and the FDA ca= n't=20 afford that."=20 #ArticleCommentsWrapper {display:block};=20 FAIR USE NOTICE: This may contain copyrighted (=A9 ) material the use of wh= ich=20 has not always been specifically authorized by the copyright owner. Such=20 material is made available for educational purposes, to advance understandi= ng of=20 human rights, democracy, scientific, moral, ethical, and social justice=20 issues, etc. It is believed that this constitutes a 'fair use' of any such=20 copyrighted material as provided for in Title 17 U.S.C. section 107 of the=20= US=20 Copyright Law. This material is distributed without profit. The information herein shall not be considered an endorsement of anyone =20 discontinuing psychiatric drugs. If you are stopping taking medication IT=20= IS=20 ADVISABLE TO REDUCE DOSES GRADUALLY WITH EXTREME CAUTION, as it is difficu= lt=20 to predict who will have problems withdrawing. It is worth getting as much=20 information and support as you can, and involving your doctor wherever=20 possible. You will find withdrawal information here: =20 http:/_/www.mind.org.uk/Information/Booklets/Making+sense/Making+sense+of+co= ming+off+psychiatric+drugs.ht m_=20 (http://www.mind.org.uk/Information/Booklets/Making+sense/Making+sense+of+co= ming+off+psychiatric+drugs.htm)=20 FOR MORE INFORMATION ON WITHDRAWAL:: Get Peter Lehmann's book, _Coming off= =20 Psychiatric Drugs: Successful Withdrawal from Neuroleptics, Antidepressants,= =20 Lithium, Carbamazepine and Tranquilizers_=20 (http://www.peter-lehmann-publishing.com/withdraw.htm) . This valuable res= ource comes in US, UK, Greek. and=20 German editions. **************Finally, one site has it all: your friends, your email, your=20 favorite sites. Try the NEW AOL.com.=20 (http://www.aol.com/?optin=3Dnew-dp&icid=3Daolcom40vanity&ncid=3Demlcntaolco= m00000006) [Non-text portions of this message have been removed] --ae0JBvv8mj4sUY8uwu4aZQ09X2HVQhy2gLGyPMn Content-Type: text/html; charset=ISO-8859-1 Content-Transfer-Encoding: quoted-printable <!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html= 4/strict.dtd"> <html> <head> </head> <body style=3D"background-color: #ffffff;"> <!--~-|**|PrettyHtmlStartT|**|-~--> <div id=3D"ygrp-mlmsg" style=3D"width:655px; position:relative;"> <div id=3D"ygrp-msg" style=3D"width: 470px; margin:0; padding:0 25px 0 0; fl= oat:left; z-index:1;"> <!--~-|**|PrettyHtmlEndT|**|-~--> <div id=3D"ygrp-text"> <p> <br> In a message dated 11/28/2008 10:52:41 A.M. Central Standard Time, <br> <a href=3D"mailto:vince_19805%40yahoo.com">vince_19805@<wbr>yahoo.com</a> wr= ites:<br> <br> **** note: This is a private list. I send out alerts, useful news items= , <br> and comment to a group of mental health professionals, decision makers and=20= <br> activists. (OK to repost and to include this header and comments). If you=20= do <br> not want to receive any of these emails, please let me know. To preserve <b= r> privacy, I blind copy the entire list. Vince Boehm **** <br> <br> _<a href=3D"http://www.washingtonpost.com/wp-dyn/content/article/2008/11/25/= AR20081125022">http://www.washingt<wbr>onpost.com/<wbr>wp-dyn/content/<wbr>a= rticle/2008/<wbr>11/25/AR20081125<wbr>022</a><br> 19_pf.html_ <br> (<a href=3D"http://www.washingtonpost.com/wp-dyn/content/article/2008/11/25/= AR2008112502219_pf.html">http://www.washingt<wbr>onpost.com/<wbr>wp-dyn/cont= ent/<wbr>article/2008/<wbr>11/25/AR20081125<wbr>02219_pf.<wbr>html</a>) <br> <br> Ailing FDA May Need a Major Overhaul, Officials and Groups Say<br> _Post a comment_ <br> (<a href=3D"http://www.washingtonpost.com/wp-dyn/content/article/2008/11/25/= AR2008112502219_Comments.html">http://www.washingt<wbr>onpost.com/<wbr>wp-dy= n/content/<wbr>article/2008/<wbr>11/25/AR20081125<wbr>02219_Comments.<wbr>ht= ml</a>) <br> <br> By Rob Stein<br> Washington Post Staff Writer<br> Wednesday, November 26, 2008; A02<br> <br> The _Obama_ <br> (<a href=3D"http://www.washingtonpost.com/ac2/related/topic/Barack+Obama?tid= =3Dinformline">http://www.washingt<wbr>onpost.com/<wbr>ac2/related/<wbr>topi= c/Barack+<wbr>Obama?tid=3D<wbr>informline</a>) administration will inhe= rit a _Food and Drug Administration_ <br> (<a href=3D"http://www.washingtonpost.com/ac2/related/topic/Food+and+Drug+Ad= ministration?tid">http://www.washingt<wbr>onpost.com/<wbr>ac2/related/<wbr>t= opic/Food+<wbr>and+Drug+<wbr>Administration?<wbr>tid</a><br> =3Dinformline) widely seen as struggling to protect Americans from unsafe=20= <br> medication, contaminated food and a flood of questionable imports from Chin= a and <br> other countries. <br> Shaken by a series of alarming failures, the FDA desperately needs an <br> infusion of strong leadership, money, technology and personnel -- and perha= ps a <br> major restructuring, say former officials, members of Congress, watchdog gr= oups <br> and various government reports. <br> "Everywhere you go, you hear the same chorus: The agency's in trouble,= " said <br> David A. Kessler, who served as FDA commissioner under Presidents _George <= br> H.W. Bush_ <br> (<a href=3D"http://www.washingtonpost.com/ac2/related/topic/George+H.W.+Bush= ?tid=3Dinformline">http://www.washingt<wbr>onpost.com/<wbr>ac2/related/<wbr>= topic/George+<wbr>H.W.+Bush?<wbr>tid=3Dinformline</a>) and _Bill Cl= inton_ <br> (<a href=3D"http://www.washingtonpost.com/ac2/related/topic/Bill+Clinton?tid= =3Dinformline">http://www.washingt<wbr>onpost.com/<wbr>ac2/related/<wbr>topi= c/Bill+<wbr>Clinton?tid=3D<wbr>informline</a>) . "There's a general= perception the agency is <br> suffering mightily." <br> With nearly 11,000 employees and an annual budget of more than $2 billion,=20= <br> the FDA is charged with overseeing products that account for one-quarter of= <br> consumer spending in the United States, including over-the-counter and <br> prescription medications, heart valves, stents and other medical devices, t= he blood <br> supply, and food. <br> But morale within the FDA, along with its credibility outside, has plummete= d <br> as the agency has been stretched to keep pace with its responsibilities and= <br> riven by accusations of ideological bias, a tilt toward industry rather than= <br> consumers, and internal dissension. <br> "FDA is close to being at a tipping point -- the agency is hanging on=20= by its <br> fingertips in protecting us," said William K. Hubbard, who worked for=20= the <br> agency for 27 years. "If something is not done, they could become a fai= led <br> institution, and no one wants that. The FDA is not only important to protec= ting <br> the public health but also to the industries it regulates." <br> Alarm about the agency began to spike after a series of highly publicized =20= <br> incidents, including the discovery that the painkiller _Vioxx_ <br> (<a href=3D"http://www.washingtonpost.com/ac2/related/topic/Vioxx?tid=3Dinfo= rmline">http://www.washingt<wbr>onpost.com/<wbr>ac2/related/<wbr>topic/Vioxx= ?<wbr>tid=3Dinformline</a>) caused heart attacks. <br> That has been followed by other safety issues, including questions about th= e <br> widely used diabetes medication _Avandia_ <br> (<a href=3D"http://www.washingtonpost.com/ac2/related/topic/Avandia?tid=3Din= formline">http://www.washingt<wbr>onpost.com/<wbr>ac2/related/<wbr>topic/Ava= ndia?<wbr>tid=3Dinformline</a>) and several psychiatric drugs. <br> "I'm afraid we're going to see more horrible things happen if we don't= get <br> our act together on this," said _David Ross_ <br> (<a href=3D"http://www.washingtonpost.com/ac2/related/topic/David+Ross?tid= =3Dinformline">http://www.washingt<wbr>onpost.com/<wbr>ac2/related/<wbr>topi= c/David+<wbr>Ross?tid=3D<wbr>informline</a>) , who was a drug reviewer a= t the <br> agency for 10 years. <br> At the same time, there has been increasing alarm about the agency's abilit= y <br> to protect the food supply -- concerns highlighted by recent major outbreak= s <br> of E. coli infection in spinach and salmonella in spinach and peppers. Tha= t <br> has prompted calls to split the agency in two -- with one dedicated to drug= s <br> and the other to food. <br> "Food safety tends to get short shrift," said Christopher Waldrop= of the <br> _Consumer Federation of America_ <br> (<a href=3D"http://www.washingtonpost.com/ac2/related/topic/Consumer+Federat= ion+of+America?tid=3Dinformline">http://www.washingt<wbr>onpost.com/<wbr>ac2= /related/<wbr>topic/Consumer+<wbr>Federation+<wbr>of+America?<wb= r>tid=3Dinformline</a>) . "The drug side tends to get <br> much more attention than the food side. Food is equally important and needs=20= <br> to get the attention it deserves." <br> Both the food and drug parts of the FDA's responsibilities have been hobble= d <br> by its inability to adequately monitor goods pouring into the United States= <br> from around the world, including food, drugs and raw materials, many say. <= br> Such concerns were highlighted by contaminated toothpaste from China; taint= ed <br> pet food that killed hundreds of dogs and cats; and the fouled blood thinne= r <br> heparin, which took the lives of at least 81 Americans and caused hundreds=20= of <br> serious illnesses. <br> "The agency is still stuck at the border," said Carl R. Nielsen,=20= who was in <br> charge of the FDA's import operations for the last six of his 28 years at <= br> the agency. "There has to be radical reorganization -- no doubt about =20= that." <br> Although the FDA has started opening offices overseas to try to better <br> police safety standards at the source, experts say much more needs to be do= ne. For <br> starters, the agency needs to sharply boost inspections abroad, develop <br= > strict new regulatory standards, and update and integrate its computer syst= ems, <br> which are woefully antiquated and disjointed, Nielsen and others said. <br> "It's still largely a paper-driven agency," Nielsen said. "T= he agency has <br> great information pigeonholed all over the place, but it cannot be applied=20= in <br> real time, which is what you need today." <br> The FDA has also been one of the many federal agencies where Bush <br> administration critics say ideology has trumped science, citing the long de= lay in <br> approving the over-the-counter sale of the emergency contraceptive Plan B.= <br> "The agency needs to get back to using science as the basis for its <= br> decision-making,<wbr>" said Jane E. Henney, who ran the FDA under Clint= on from 1998 to <br> 2001. <br> Questions have also been raised about the agency's handling of suspected <b= r> toxins such as bisphenol A in baby bottles and other products. And internal= <br> dissension has erupted publicly from the usually hermetically sealed agency= . Last <br> week, the _House Energy and Commerce Committee_ <br> (<a href=3D"http://www.washingtonpost.com/ac2/related/topic/U.S.+House+Commi= ttee+on+Energy+and+Commerce?tid=3Dinformline">http://www.washingt<wbr>onpost= .com/<wbr>ac2/related/<wbr>topic/U.S.<wbr>+House+Committee<wbr>+= on+Energy+<wbr>and+Commerce?<wbr>tid=3Dinformline</a>)<br> released a letter from FDA scientists complaining about "serious <br= > misconduct" by top managers who oversee medical devices. <br> The turmoil comes as the FDA is facing a host of new demands, including the= <br> next wave of drugs and other products resulting from breakthroughs in <br> genetics, nanotechnology and bioengineered foods, among others. And Congres= s may <br> give the FDA the power to regulate tobacco for the first time. <br> "This would be a totally new regulatory responsibility that the FDA do= esn't <br> have expertise in," said Mark B. McClellan, who led the agency in Pres= ident <br> _George W. Bush_ <br> (<a href=3D"http://www.washingtonpost.com/ac2/related/topic/George+W.+Bush?t= id=3Dinformline">http://www.washingt<wbr>onpost.com/<wbr>ac2/related/<wbr>to= pic/George+<wbr>W.+Bush?tid=3D<wbr>informline</a>) 's first term. <b= r> While the agency has received some additional money and personnel to help =20= <br> implement new drug safety powers, many say it is overdue for a doubling of =20= its <br> budget. <br> "There's broad bipartisan recognition from consumer groups and from in= dustry <br> that the FDA needs more resources," McClellan said. "The most imp= ortant <br> thing is overall effective leadership that leads in a way that establishes=20= public <br> trust." <br> Many hope the new administration will quickly name a new FDA commissioner -= - <br> a post that has frequently been left in the hands of acting commissioners <= br> for long periods. An acting commissioner ran the agency for more than half=20= of <br> the past eight years. <br> "The FDA can't be left to drift," said Hubbard, the former offici= al. <br> "There's a lack of leadership when a caretaker is in charge, and the F= DA can't <br> afford that." <br> <br> #ArticleCommentsWra<wbr>pper {display:block}<wbr>; <br> <br> FAIR USE NOTICE: This may contain copyrighted (=A9 ) material the use of wh= ich <br> has not always been specifically authorized by the copyright owner. Such <b= r> material is made available for educational purposes, to advance understandi= ng of <br> human rights, democracy, scientific, moral, ethical, and social justice <br= > issues, etc. It is believed that this constitutes a 'fair use' of any such=20= <br> copyrighted material as provided for in Title 17 U.S.C. section 107 of the=20= US <br> Copyright Law. This material is distributed without profit.<br> <br> The information herein shall not be considered an endorsement of anyone <b= r> discontinuing psychiatric drugs. If you are stopping taking medication IT=20= IS <br> ADVISABLE TO REDUCE DOSES GRADUALLY WITH EXTREME CAUTION, as it is difficu= lt <br> to predict who will have problems withdrawing. It is worth getting as much=20= <br> information and support as you can, and involving your doctor wherever <br> possible. You will find withdrawal information here: <br> http:/_/www.<wbr>mind.org.<wbr>uk/Information/<wbr>Booklets/<wbr>Making+= sense/<wbr>Making+sense+<wbr>of+coming+<wbr>off+psychiat= ric+<wbr>drugs.ht<br> m_ <br> (<a href=3D"http://www.mind.org.uk/Information/Booklets/Making+sense/Making+= sense+of+coming+off+psychiatric+drugs.htm">http://www.mind.<wbr>org.uk/Infor= mati<wbr>on/Booklets/<wbr>Making+sense/<wbr>Making+sense+<wbr>of= +coming+<wbr>off+psychiatric+<wbr>drugs.htm</a>) <br> <br> FOR MORE INFORMATION ON WITHDRAWAL:: Get Peter Lehmann's book, _Coming off= <br> Psychiatric Drugs: Successful Withdrawal from Neuroleptics, Antidepressants,= <br> Lithium, Carbamazepine and Tranquilizers_ <br> (<a href=3D"http://www.peter-lehmann-publishing.com/withdraw.htm">http://www= .peter-<wbr>lehmann-publishi<wbr>ng.com/withdraw.<wbr>htm</a>) . This valu= able resource comes in US, UK, Greek. and <br> German editions.<br> <br> ************<wbr>**Finally, one site has it all: your friends, your email, y= our <br> favorite sites. Try the NEW AOL.com. <br> (<a href=3D"http://www.aol.com/?optin=3Dnew-dp&icid=3Daolcom40vanity&amp= ;ncid=3Demlcntaolcom00000006">http://www.aol.<wbr>com/?optin=3D<wbr>new-dp&a= mp;icid=3D<wbr>aolcom40vanity&<wbr>ncid=3Demlcntaolco<wbr>m00000006</a>)= <br> <br> [Non-text portions of this message have been removed]<br> <br> </p> </div> =20 <!--~-|**|PrettyHtmlStart|**|-~--> <span width=3D"1" style=3D"color: white;">__._,_.___</span> <!-- Start the section with Message In topic --> <div id=3D"ygrp-actbar"> <span class=3D"left"> <a href=3D"http://groups.yahoo.com/group/wildestcolts/message/1347= 0;_ylc=3DX3oDMTM2cjhobWFoBF9TAzk3MzU5NzE0BGdycElkAzI0MjUzMTAEZ3Jwc3BJZAMxNzA= 1MDYyMjE1BG1zZ0lkAzEzNDcwBHNlYwNmdHIEc2xrA3Z0cGMEc3RpbWUDMTIyNzkwNzk5NAR0cGN= JZAMxMzQ3MA--"> Messages in this topic </a> (<span class=3D"bld">1</spa= n>) </span> <a href=3D"http://groups.yahoo.com/group/wildestcolts/post;_ylc=3DX3= oDMTJxcWF1OGY5BF9TAzk3MzU5NzE0BGdycElkAzI0MjUzMTAEZ3Jwc3BJZAMxNzA1MDYyMjE1BG= 1zZ0lkAzEzNDcwBHNlYwNmdHIEc2xrA3JwbHkEc3RpbWUDMTIyNzkwNzk5NA--?act=3Dreply&m= essageNum=3D13470"> <span class=3D"bld"> Reply </span> (via web post) </a> |=20 <a href=3D"http://groups.yahoo.com/group/wildestcolts/post;_ylc=3DX3= oDMTJlM25ocGc2BF9TAzk3MzU5NzE0BGdycElkAzI0MjUzMTAEZ3Jwc3BJZAMxNzA1MDYyMjE1BH= NlYwNmdHIEc2xrA250cGMEc3RpbWUDMTIyNzkwNzk5NA--" class=3D"bld"> Start a new topic </a> </div>=20 <!------- Start Nav Bar ------> <!-- |**|begin egp html banner|**| --> <div id=3D"ygrp-vitnav"> <a href=3D"http://groups.yahoo.com/group/wildestcolts/messag= es;_ylc=3DX3oDMTJlazNhazFnBF9TAzk3MzU5NzE0BGdycElkAzI0MjUzMTAEZ3Jwc3BJZAMxNz= A1MDYyMjE1BHNlYwNmdHIEc2xrA21zZ3MEc3RpbWUDMTIyNzkwNzk5NA--">Messages</a> =20 | <a href=3D"http://groups.yahoo.com/group/wildestcolts/files= ;_ylc=3DX3oDMTJmb2lqNTJxBF9TAzk3MzU5NzE0BGdycElkAzI0MjUzMTAEZ3Jwc3BJZAMxNzA1= MDYyMjE1BHNlYwNmdHIEc2xrA2ZpbGVzBHN0aW1lAzEyMjc5MDc5OTQ-">Files</a> =20 | <a href=3D"http://groups.yahoo.com/group/wildestcolts/photo= s;_ylc=3DX3oDMTJlMzg0NDd0BF9TAzk3MzU5NzE0BGdycElkAzI0MjUzMTAEZ3Jwc3BJZAMxNzA= 1MDYyMjE1BHNlYwNmdHIEc2xrA3Bob3QEc3RpbWUDMTIyNzkwNzk5NA--">Photos</a> =20 | <a href=3D"http://groups.yahoo.com/group/wildestcolts/links= ;_ylc=3DX3oDMTJmYTZxcmtoBF9TAzk3MzU5NzE0BGdycElkAzI0MjUzMTAEZ3Jwc3BJZAMxNzA1= MDYyMjE1BHNlYwNmdHIEc2xrA2xpbmtzBHN0aW1lAzEyMjc5MDc5OTQ-">Links</a> =20 | <a href=3D"http://groups.yahoo.com/group/wildestcolts/datab= ase;_ylc=3DX3oDMTJjczkycDM5BF9TAzk3MzU5NzE0BGdycElkAzI0MjUzMTAEZ3Jwc3BJZAMxN= zA1MDYyMjE1BHNlYwNmdHIEc2xrA2RiBHN0aW1lAzEyMjc5MDc5OTQ-">Database</a> =20 | <a href=3D"http://groups.yahoo.com/group/wildestcolts/polls= ;_ylc=3DX3oDMTJmbWQyaWlxBF9TAzk3MzU5NzE0BGdycElkAzI0MjUzMTAEZ3Jwc3BJZAMxNzA1= MDYyMjE1BHNlYwNmdHIEc2xrA3BvbGxzBHN0aW1lAzEyMjc5MDc5OTQ-">Polls</a> =20 | <a href=3D"http://groups.yahoo.com/group/wildestcolts/membe= rs;_ylc=3DX3oDMTJlZ3A5cmpnBF9TAzk3MzU5NzE0BGdycElkAzI0MjUzMTAEZ3Jwc3BJZAMxNz= A1MDYyMjE1BHNlYwNmdHIEc2xrA21icnMEc3RpbWUDMTIyNzkwNzk5NA--">Members</a> =20 | <a href=3D"http://groups.yahoo.com/group/wildestcolts/calen= dar;_ylc=3DX3oDMTJkbzVyZjB1BF9TAzk3MzU5NzE0BGdycElkAzI0MjUzMTAEZ3Jwc3BJZAMxN= zA1MDYyMjE1BHNlYwNmdHIEc2xrA2NhbARzdGltZQMxMjI3OTA3OTk0">Calendar</a> =20 </div> =20 <!-- |**|end egp html banner|**| --> <div id=3D"ygrp-grft"> =20 <!-- |**|begin egp html banner|**| --> REMINDERS:<BR> Please help minimize the number of emails received by the entire membership=20= by sending responses of a personal nature directly to the author. When you c= lick "reply" you must delete the wildestcolts address and type in=20= the author's address.<BR> It is acceptable to attack a theory, but not the member. Attachments are not= allowed to prevent the spread of viruses to our membership. =20 <!-- |**|end egp html banner|**| --> </div> =20 <div id=3D"ygrp-mkp"> <div id=3D"hd">MARKETPLACE</div> <div id=3D"ads"> <div class=3D"ad"> <hr noshade=3D"noshade" size=3D"1"><a href=3D"http://us.ard.yaho= o.com/SIG=3D13ukgu8q2/M=3D493064.12016295.13271503.10835568/D=3Dgrphealth/S= =3D1705062215:MKP1/Y=3DYAHOO/EXP=3D1227915194/L=3D/B=3DRyEnJ0LaX.w-/J=3D1227= 907994726393/A=3D5530388/R=3D0/SIG=3D11nuutlas/*http://explore.yahoo.com/gro= ups/kraftmealsmadesimple/">From kitchen basics to easy recipes - join the Gr= oup from Kraft Foods </a> </div> </div> </div> =20 <!-- yahoo logo --> <!-- |**|begin egp html banner|**| --> <div id=3D"ygrp-ft"> <a href=3D"http://groups.yahoo.com/;_ylc=3DX3oDMTJkdG5mZHNrBF9TAzk3MzU= 5NzE0BGdycElkAzI0MjUzMTAEZ3Jwc3BJZAMxNzA1MDYyMjE1BHNlYwNmdHIEc2xrA2dmcARzdGl= tZQMxMjI3OTA3OTk0"> <img src=3D"http://us.i1.yimg.com/us.yimg.com/i/yg/img/logo/ma_grp_160= .gif" height=3D"15" width=3D"106" border=3D"0" alt=3D"Yahoo! Groups"></a> <b= r> <a href=3D"http://groups.yahoo.com/group/wildestcolts/join;_ylc=3DX3oD= MTJmZmZtYWZqBF9TAzk3MzU5NzE0BGdycElkAzI0MjUzMTAEZ3Jwc3BJZAMxNzA1MDYyMjE1BHNl= YwNmdHIEc2xrA3N0bmdzBHN0aW1lAzEyMjc5MDc5OTQ-">Change settings via the Web</a= > (Yahoo! ID required) <br> Change settings via email: <a href=3D"mailto:wildestcolts-digest@yahoo= groups.com?subject=3DEmail Delivery: Digest">Switch delivery to Daily Digest= </a> | <a href =3D "mailto:wildestcolts-traditional@yahoogroups.com?subject= =3DChange Delivery Format: Traditional">Switch format to Traditional</a> <br= > <a href=3D"http://groups.yahoo.com/group/wildestcolts;_ylc=3DX3oDMTJka= mNpdDBjBF9TAzk3MzU5NzE0BGdycElkAzI0MjUzMTAEZ3Jwc3BJZAMxNzA1MDYyMjE1BHNlYwNmd= HIEc2xrA2hwZgRzdGltZQMxMjI3OTA3OTk0"> Visit Your Group=20 </a> | <a href=3D"http://docs.yahoo.com/info/terms/"> Yahoo! Groups Terms of Use </a> | <a href=3D"mailto:wildestcolts-unsubscribe@yahoogroups.com?subject=3D"= > Unsubscribe </a>=20 </div> <!-- |**|end egp html banner|**| --> </div> <!-- ygrp-msg --> =20 <!-- Sponsor --> <!-- |**|begin egp html banner|**| --> <div id=3D"ygrp-sponsor" style=3D"width:160px; float:right; clear:none; ma= rgin:0 0 25px 0; background:white;"> <!-- Network content --> =20 <!-- Start Recommendations --> <div id=3D"ygrp-reco"> </div> <!-- End Recommendations --> <!-- Start vitality --> <div id=3D"ygrp-vital"> <div id=3D"vithd">Recent Activity</div> <ul style=3D"list-style-type:none; padding: 0; margin: 2px 0;"> <li style=3D"clear: both;"> <div class=3D"ct" style=3D"float: right;"><span style=3D"display:none"= > </span>2</div> <div class=3D"cat"><a href=3D"http://groups.yahoo.com/group/wildestcol= ts/members;_ylc=3DX3oDMTJmNWZibnFlBF9TAzk3MzU5NzE0BGdycElkAzI0MjUzMTAEZ3Jwc3= BJZAMxNzA1MDYyMjE1BHNlYwN2dGwEc2xrA3ZtYnJzBHN0aW1lAzEyMjc5MDc5OTQ-">New Memb= ers</a></div> </li> =20 =20 =20 =20 =20 =20 </ul> <a href=3D"http://groups.yahoo.com/group/wildestcolts;_ylc= =3DX3oDMTJlNjJoNHNkBF9TAzk3MzU5NzE0BGdycElkAzI0MjUzMTAEZ3Jwc3BJZAMxNzA1MDYyM= jE1BHNlYwN2dGwEc2xrA3ZnaHAEc3RpbWUDMTIyNzkwNzk5NA--"> Visit Your Group </a> </div>=20 =20 <!-- Network content --> <div id=3D"nc"> <div class=3D"ad"> <div id=3D"hd1">Meditation and</div>=20 <p><a href=3D"http://us.ard.yahoo.com/SIG=3D13rfgoi04/M=3D493064.12016231.12= 582634.9706571/D=3Dgrphealth/S=3D1705062215:NC/Y=3DYAHOO/EXP=3D1227915194/L= =3D/B=3DSCEnJ0LaX.w-/J=3D1227907994726393/A=3D5191951/R=3D0/SIG=3D11iiaadso/= *http://new.groups.yahoo.com/giftoflovingkindness">Lovingkindness</a></p>=20 <p>A Yahoo! Group</p>=20 <p>to share and learn.</p> </div> <div class=3D"ad"> <div id=3D"hd1">Yahoo! Health</div>=20 <p><a href=3D"http://us.ard.yahoo.com/SIG=3D13rhg1m39/M=3D493064.12016303.12= 582636.9706571/D=3Dgrphealth/S=3D1705062215:NC/Y=3DYAHOO/EXP=3D1227915194/L= =3D/B=3DSSEnJ0LaX.w-/J=3D1227907994726393/A=3D5191949/R=3D0/SIG=3D12teb63n5/= *http://health.yahoo.com/asthma-overview/identifying-asthma-triggers/healthw= ise--aa6768.html">Asthma Triggers</a></p>=20 <p>How you can</p>=20 <p>identify them.</p> </div> <div class=3D"ad"> <div id=3D"hd1">New business?</div>=20 <p><a href=3D"http://us.ard.yahoo.com/SIG=3D13r08u9af/M=3D493064.12016308.12= 445700.8674578/D=3Dgrphealth/S=3D1705062215:NC/Y=3DYAHOO/EXP=3D1227915194/L= =3D/B=3DSiEnJ0LaX.w-/J=3D1227907994726393/A=3D3848640/R=3D0/SIG=3D131an6mds/= *http://searchmarketing.yahoo.com/arp/srchv2.php?o=3DUS2002&cmp=3DYahoo&ctv= =3DGroups1&s=3DY&s2=3D&s3=3D&b=3D50">Get new customers.</a></p>=20 <p>List your web site</p>=20 <p>in Yahoo! Search.</p> </div> </div> =20 </div> <!-- |**|end egp html banner|**| --> <div style=3D"clear:both; color: #FFF; font-size:1px;">.</div> </div> <img src=3D"http://geo.yahoo.com/serv?s=3D97359714/grpId= =3D2425310/grpspId=3D1705062215/msgId=3D13470/stime=3D1227907994/nc1=3D51919= 51/nc2=3D5191949/nc3=3D3848640" width=3D"1" height=3D"1"> <br> =20 <span style=3D"color: white;">__,_._,___</span> <!--~-|**|PrettyHtmlEnd|**|-~--> </body> <!--~-|**|PrettyHtmlStart|**|-~--> <head> <style type=3D"text/css"> <!-- #ygrp-mkp{ border: 1px solid #d8d8d8; font-family: Arial; margin: 14px 0px; padding: 0px 14px; } #ygrp-mkp hr{ border: 1px solid #d8d8d8; } #ygrp-mkp #hd{ color: #628c2a; font-size: 85%; font-weight: bold; line-height: 122%; margin: 10px 0px; } #ygrp-mkp #ads{ margin-bottom: 10px; } #ygrp-mkp .ad{ padding: 0 0; } #ygrp-mkp .ad a{ color: #0000ff; text-decoration: none; } --> </style> </head> <head> <style type=3D"text/css"> <!-- #ygrp-sponsor #ygrp-lc{ font-family: Arial; } #ygrp-sponsor #ygrp-lc #hd{ margin: 10px 0px; font-weight: bold; font-size: 78%; line-height: 122%; } #ygrp-sponsor #ygrp-lc .ad{ margin-bottom: 10px; padding: 0 0; } --> </style> </head> <head> <style type=3D"text/css"> <!-- =09#ygrp-mlmsg {font-size:13px; font-family: arial,helvetica,clean,sans-seri= f;*font-size:small;*font:x-small;} =09#ygrp-mlmsg table {font-size:inherit;font:100%;} =09#ygrp-mlmsg select, input, textarea {font:99% arial,helvetica,clean,sans-= serif;} =09#ygrp-mlmsg pre, code {font:115% monospace;*font-size:100%;} =09#ygrp-mlmsg * {line-height:1.22em;} =09#ygrp-text{ =09 font-family: Georgia;=09 =09} =09#ygrp-text p{ =09 margin: 0 0 1em 0; =09} =09#ygrp-tpmsgs{ =09 font-family: Arial;=09 =09 clear: both; =09} =09#ygrp-vitnav{ =09=09padding-top: 10px; =09=09font-family: Verdana; =09=09font-size: 77%; =09=09margin: 0; =09} =09#ygrp-vitnav a{ =09=09padding: 0 1px; =09} =09#ygrp-actbar{ =09=09clear: both; =09=09margin: 25px 0; =09=09white-space:nowrap; =09=09color: #666; =09=09text-align: right; =09} =09#ygrp-actbar .left{ =09=09float: left; =09=09white-space:nowrap; =09} =09.bld{font-weight:bold;} =09#ygrp-grft{ =09=09font-family: Verdana; =09=09font-size: 77%; =09=09padding: 15px 0; =09} =09#ygrp-ft{ =09 font-family: verdana; =09 font-size: 77%; =09 border-top: 1px solid #666;=20 =09 padding: 5px 0;=20 =09} =09#ygrp-mlmsg #logo{ =09 padding-bottom: 10px; =09} =09#ygrp-reco { =09margin-bottom: 20px; =09padding: 0px; =09} =09#ygrp-reco #reco-head { =09=09font-weight: bold; =09=09color: #ff7900; =09} =09#reco-grpname{ font-weight: bold; margin-top: 10px; =09} =09#reco-category{ =09font-size: 77%; =09} =09#reco-desc{ =09font-size: 77%; =09} =09#ygrp-vital{ =09=09background-color: #e0ecee; =09=09margin-bottom: 20px; =09=09padding: 2px 0 8px 8px; =09} =09#ygrp-vital #vithd{ =09=09font-size: 77%; =09=09font-family: Verdana; =09=09font-weight: bold; =09=09color: #333; =09=09text-transform: uppercase; =09} =09#ygrp-vital ul{ =09=09padding: 0; =09=09margin: 2px 0; =09} =09#ygrp-vital ul li{ =09 list-style-type: none; =09 clear: both; =09 border: 1px solid #e0ecee; =20 =09} =09#ygrp-vital ul li .ct{ =09 font-weight: bold; =09 color: #ff7900; =09 float: right; =09 width: 2em; =09 text-align:right; =09 padding-right: .5em; =09} =09#ygrp-vital ul li .cat{ =09 font-weight: bold; =09} =09#ygrp-vital a{ =09=09text-decoration: none; =09} =09#ygrp-vital a:hover{ =09 text-decoration: underline; =09} =09#ygrp-sponsor #hd{ =09=09color: #999; =09=09font-size: 77%; =09} =09#ygrp-sponsor #ov{ =09=09padding: 6px 13px; =09=09background-color: #e0ecee; =09=09margin-bottom: 20px; =09} =09#ygrp-sponsor #ov ul{ =09=09padding: 0 0 0 8px; =09=09margin: 0; =09} =09#ygrp-sponsor #ov li{ =09=09list-style-type: square; =09=09padding: 6px 0; =09=09font-size: 77%; =09} =09#ygrp-sponsor #ov li a{ =09=09text-decoration: none; =09=09font-size: 130%; =09} =09#ygrp-sponsor #nc{ =09 background-color: #eee; =09 margin-bottom: 20px; =09 padding: 0 8px; =09} =09#ygrp-sponsor .ad{ =09=09padding: 8px 0; =09} =09#ygrp-sponsor .ad #hd1{ =09=09font-family: Arial; =09=09font-weight: bold; =09=09color: #628c2a; =09=09font-size: 100%; =09=09line-height: 122%; =09} =09#ygrp-sponsor .ad a{ =09=09text-decoration: none; =09} =09#ygrp-sponsor .ad a:hover{ =09=09text-decoration: underline; =09} =09#ygrp-sponsor .ad p{ =09=09margin: 0; =09} =09o{font-size: 0; } =09.MsoNormal{ =09 margin: 0 0 0 0; =09} =09#ygrp-text tt{ =09 font-size: 120%; =09} =09blockquote{margin: 0 0 0 4px;} =09.replbq{margin:4} =09--> </style> </head> <!--~-|**|PrettyHtmlEnd|**|-~--> </html><!--End group email --> --ae0JBvv8mj4sUY8uwu4aZQ09X2HVQhy2gLGyPMn-- ]